header

BARDEX® I.C. Infection Control Foley Catheters

Product Images:
The BARDEX® I.C. anti-infective latex Foley catheter is clinically proven to reduce catheter-associated urinary tract infections. Incorporating a technologically-advanced formulation consisting of BACTI-GUARD®* silver alloy coating and BARD® hydrogel, the BARDEX® I.C. Foley catheter dramatically reduces bacterial adherence and minimises biofilm formation.

The occurrence of urinary tract infection is 3.7 times greater in patients catheterised with a standard catheter than in patients catheterised with the BARDEX® I.C. Foley catheter with BACTI-GUARD®* silver alloy coating and BARD® hydrogel.

Recommended indwelling time not to exceed 28 days2.
 
 

Features and Specifications

Balloon SizeCommunity Product Code (Standard Length)Community Product Code (Female Length)Hospital Product Code (Standard Length)Hospital Product Code (Female Length)
BARDEX® I.C. AQUAFIL® Foley Catheter with Bacti-Guard®* Silver Alloy Coating and BARD® Hydrogel (With pre-filled syringe of sterile water)
10mLD236512SD236912S236512UKS236912UKS
10mLD236514SD236914S236514UKS236914UKS
10mLD236516SD236916S236516UKS236916UKS
10mLD236518S-236518UKS-
10mLD236520S-236520UKS-
10mLD236522S-236522UKS-
10mL--236524UKS-

Specifications subject to change without notice. The Foley catheters included in the BARDEX® I.C. System contain Bacti-Guard® silver alloy coating licensed from Bactiguard AB. Bacti-Guard is a registered trademark of Bactiguard AB. Please consult product labels and inserts for any indications, contraindications, hazards, warnings, cautions and instructions for use 1. Clinical studies available on file at Bard Limited 2. Refer to manufacturers guidelines

ADVANTAGES

  • Reduces bacterial adherence
  • Minimizes biofilm formation
  • Inhibits migration of pathogens into the bladder
  • Preserves the integrity of the urethral mucosa
  • Clinically proven to reduce catheter-associated urinary tract infections1

Literature

BARDEX IC BROCHURE.pdf

NTAC Briefing Pack

NHS Technology Adoption Centre (NTAC), commissioned by the Department of Health to encourage wider adoption of high impact innovative medical technologies, has published a BARDEX® I.C. Technology Briefing Pack. The pack provides comprehensive information and adoption considerations for clinical teams and NHS organisations and a summary of the costing information supplied by Bard to the Department of Health’s Innovative Technology Adoption Procurement Programme (iTAPP).  The packs are available to NHS staff and can be downloaded by registering on the NTAC web-site:  www.ntac.nhs.uk/Login.aspx?Type=AREA


Contact Us

read more